About Endovel Pharmaceuticals Private Limited
Data last updated:
Endovel Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 05 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24100PN2019PTC186496. Its GSTIN is 10AAFCE6275K1ZM (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Mohammad Taimur Ahmad Sahabaz (Managing Director) and Ayesha Salma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H/O Abdur Rahman A – Wing/101 Rythem Tower 100 Ft Road Naya Nagar Mira Road East, Thane, Maharashtra, India – 401107.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.3 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹2.34 Lakh (net margin 1.8%) and EBITDA of ₹4.88 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 62% over five years.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
For more details, the company can be reached via its website endovelpharma.com.
Company details
Contact details
Endovel Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is endovelpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressH/O Abdur Rahman A – Wing/101 Rythem Tower 100 Ft Road Naya Nagar Mira Road East, Thane, Maharashtra, India – 401107
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Endovel Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Endovel Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Endovel Pharmaceuticals Private Limited, buy the company report.
Financials of Endovel Pharmaceuticals Private Limited
FY 2025 filings availableEndovel Pharmaceuticals Private Limited reported revenue of ₹1.3 Cr (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 62%. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Endovel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Endovel Pharmaceuticals Private Limited
Endovel Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Taimur Ahmad Sahabaz Also directs: Precision Specialities (OPC) Private Limited | Managing Director | 05 Sep 2019 | 7 Years 2 Months | Current |
| Ayesha Salma | Additional Director | 08 Jan 2024 | 2 Years 9 Months | Current |
Auditor
Endovel Pharmaceuticals Private Limited is audited by ABUBAKAR & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABUBAKAR & CO | FY 2023 | 030855C |
Shareholding
The shareholding of Endovel Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Endovel Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Nov 2024 | 101025860 | Uco Bank | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Endovel Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Endovel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Endovel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAFCE6275K1ZM | Bihar | Active | 06 Dec 2019 |
To see the full GST registrations and return filing status of Endovel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Endovel Pharmaceuticals Private Limited has 10 board changes on record since 2019: 6 appointments and 4 cessations. The latest: Ayesha Salma was appointed as Additional Director on 08 Jan 2024.
2 earlier events are in the company report.
Frequently asked questions
Endovel Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 05 September 2019 (7+ years old) and is registered under CIN U24100PN2019PTC186496.
Endovel Pharmaceuticals has 2 current directors:
- Mohammad Taimur Ahmad Sahabaz - Managing Director
- Ayesha Salma - Additional Director
The latest financial statements of Endovel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Endovel Pharmaceuticals is 10AAFCE6275K1ZM, registered in Bihar.
The CIN (Corporate Identification Number) of Endovel Pharmaceuticals is U24100PN2019PTC186496. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Endovel Pharmaceuticals was incorporated on 05 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
Ayesha Salma was appointed as Additional Director on 08 Jan 2024. Mohammad Sams Tabrez Alam ceased to be Director on 08 Jan 2024. Sakil Ahmad ceased to be Director on 03 Jul 2023. Endovel Pharmaceuticals has 10 board changes on record in total.
Endovel Pharmaceuticals can be reached through the website endovelpharma.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Endovel Pharmaceuticals is at HO Abdur Rahman A – Wing101 Rythem Tower 100 Ft Road Naya Nagar Mira Road East, Thane, Maharashtra, India – 401107.
Endovel Pharmaceuticals operates in the business outsourcing industry, in the business and IT consulting segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
